913567-99-4

Basic information

• Product Name: 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazol-3-amine
• Synonyms: 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazol-3-amine
• CAS NO: 913567-99-4
• Molecular Weight: 327.813
• Mol File: 913567-99-4.mol

Chemical Properties

• CAS DataBase Reference: 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazol-3-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazol-3-amine(913567-99-4)
• EPA Substance Registry System: 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazol-3-amine(913567-99-4)

Safety Data

• Hazardous Substances Data: 913567-99-4(Hazardous Substances Data)

Upstream product

• 851205-62-4 1-(5-chloro-2-hydroxybenzyl)-5-methyl-1H-pyrazole-3-carboxylic acid ethyl ester 
• 851204-79-0 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazole-3-carboxylic acid 
• 913566-76-4 ethyl 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazole-3-carboxylate 
• 100-39-0 benzyl bromide 

Downstream Products

• 913569-96-7 [1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazol-3-yl]formamide 
• 913572-12-0 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazole-3-sulfonyl chloride 
• 913569-72-9 C₂₇H₂₇ClN₄O₂ 
• 913569-74-1 C₂₆H₂₂ClF₂N₃O₂ 
• 913569-73-0 C₂₅H₂₁ClF₂N₄O₂ 
• 913566-99-1 C₂₅H₂₃ClN₄O₃ 
• 913567-04-1 C₂₃H₂₄ClN₃O₄ 
• 913572-13-1 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-5-methyl-1H-pyrazole-3-sulfonamide 
• 913569-97-8 1-({5-chloro-2-[(phenylmethyl)oxy]phenyl}methyl)-N,5-dimethyl-1H-pyrazol-3-amine 

Relevant articles and documents

Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy

Replacement of the carboxylic acid group in a series of previously described methylene-linked pyrazole EP1 receptor antagonists led to the discovery of amide, reversed amide and carbamate derivatives. Two compounds, 10a and 10b, were identified

PYRAZOLE COMPOUNDS AS PROSTAGLANDIN RECEPTORS LIGANDS

Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein Z, R1 ,R2a, R2b, R10, R11 and Rx are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.